Your browser doesn't support javascript.
loading
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study.
Mohty, Mohamad; Terpos, Evangelos; Mateos, Maria-Victoria; Cavo, Michele; Lejniece, Sandra; Beksac, Meral; Bekadja, Mohamed Amine; Legiec, Wojciech; Dimopoulos, Meletios; Stankovic, Svetlana; Durán, Maria Soledad; De Stefano, Valerio; Corso, Alessandro; Kochkareva, Yulia; Laane, Edward; Berthou, Christian; Salwender, Hans; Masliak, Zvenyslava; Peceliunas, Valdas; Willenbacher, Wolfgang; Silva, João; Louw, Vernon; Nemet, Damir; Borbényi, Zita; Abadi, Uri; Pedersen, Robert Schou; Cernelc, Peter; Potamianou, Anna; Couturier, Catherine; Feys, Caroline; Thoret-Bauchet, Florence; Boccadoro, Mario.
Afiliación
  • Mohty M; Hematology and Cellular Therapy Department, Saint-Antoine Hospital, Pierre & Marie Curie University, Paris, France. Electronic address: mohamad.mohty@inserm.fr.
  • Terpos E; Hematology and Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece.
  • Mateos MV; Servicio de Hematologia, Hospital Universitario de Salamanca, Centro de Investigación del Cáncer, Instituto de Biología Molecular y Cellular del Cáncer (Universitario de Salamanca-Consejo Superior de Investigaciones Científicas), Salamanca, Spain.
  • Cavo M; Seràgnoli Institute of Hematology, University of Bologna, Bologna, Italy.
  • Lejniece S; Department of Doctoral Studies, Riga Stradins University, Riga, Latvia.
  • Beksac M; Department of Hematology, Ankara University, Ankara, Turkey.
  • Bekadja MA; Hematology and Cell Therapy, Etablissement Hospitalier Universitaire, Oran, Algeria.
  • Legiec W; Department Hemato-Oncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland.
  • Dimopoulos M; Hematology and Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece.
  • Stankovic S; University Clinic of Hematology, Medical Faculty, Skopje, Macedonia.
  • Durán MS; Hematologia, Complejo Hospitalario de Jaén, Jaén, Spain.
  • De Stefano V; Institute of Hematology, Catholic University, Rome, Italy.
  • Corso A; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, University of Pavia, Pavia, Italy.
  • Kochkareva Y; State Budget Healthcare Institution of Moscow, City Outpatient Clinic, 68 of Healthcare Department of Moscow, Branch 3, Moscow, Russia.
  • Laane E; North Estonia Medical Centre Foundation, Tallinn, Estonia.
  • Berthou C; Université de Bretagne Occidentale, Brest, France.
  • Salwender H; Multiples Myelom, Asklepios Klinik Altona, Hamburg, Germany.
  • Masliak Z; Institute of Blood Pathology and Transfusion Medicine, Lviv, Ukraine.
  • Peceliunas V; Hematology, Oncology, and Transfusion Medicine Center, Vilnius University Hospital, Santariskiu Klinikos, Vilnius, Lithuania.
  • Willenbacher W; Universitätsklinik Innsbruck Innere Medizin V, and Oncotyrol - Center for Personalized Cancer Medicine, Innsbruck, Austria.
  • Silva J; Department of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada.
  • Louw V; Department of Internal Medicine, University of the Free State, Bloemfontein, South Africa.
  • Nemet D; Internal Medicine, Clinical Hospital Centre Zagreb, Zagreb, Croatia.
  • Borbényi Z; Szegedi Tudomanyegyetem, II. Belgyógyászati Klinika, Szeged, Hungary.
  • Abadi U; Hematology, Meir Medical Center, Kfar Saba, Israel.
  • Pedersen RS; Regionshospitalet i Holstebro, Medicinsk Afdeling, Holstebro, Denmark.
  • Cernelc P; Division of Internal Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Potamianou A; Janssen-Cilag, Neuss, Germany.
  • Couturier C; Janssen-Cilag, Issy-les-Moulineaux, France.
  • Feys C; Janssen Research and Development, Beerse, Belgium.
  • Thoret-Bauchet F; Janssen-Cilag, Issy-les-Moulineaux, France.
  • Boccadoro M; Myeloma Unit, Division of Hematology, Città della Salute e della Scienza, University of Torino, Turin, Italy.
Clin Lymphoma Myeloma Leuk ; 18(10): e401-e419, 2018 10.
Article en En | MEDLINE | ID: mdl-30030033
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pautas de la Práctica en Medicina / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Recuperativa / Mieloma Múltiple / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pautas de la Práctica en Medicina / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Recuperativa / Mieloma Múltiple / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article